Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 196 (RNA5SP196) is annotated as a **pseudogene related to 5S ribosomal RNA**. Pseudogenes are genomic sequences similar to functional genes but are generally non-functional due to mutations, deletion, or lack of transcription[5][4]. 5S ribosomal RNA itself is a well-characterized structural component of the large ribosomal subunit involved in ribosome function and protein synthesis[1][3], but RNA5SP196 does not encode a functional 5S rRNA. Unlike active 5S rRNA genes, this pseudogene has no known function, clinical significance, or therapeutic relevance. There is no evidence in the literature of RNA5SP196 participating in disease, acting as a biomarker, or serving as a target for drugs or therapies. Its presence is primarily of interest for genomic annotation and possibly evolutionary studies.
None reported
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 196 (RNA5SP196).